Browsing “Uncategorized | EVERSANA”

EVERSANA Sponsors the World Orphan Drug Congress USA

EVERSANA is proud to sponsor the 2020 virtual edition of World Orphan Drug Congress USA. This year’s event will feature over 260 presentations covering all aspects of orphan drug development and rare disease research. As dedicated advocates of the rare disease community, EVERSANA is on a mission to advance the commercialization of orphan drugs and […]

EVERSANA Sponsors Medicaid Drug Rebate Program Summit

Join us at the  Virtual 2020 Medicaid Drug Rebate Program Summit, September 14-16. The summit provides unparalleled access to the government regulators creating the rules, the industry leaders interpreting them, and the pharmaceutical executives implementing them. This year, join us for the following session, presented by Mike Kurland, one of our experts in Government Pricing and […]

EVERSANA to present at the Virtual ISPOR 2020

Analyze, Deliver, Measure and Communicate Value at Every Stage of the Product Lifecycle. Join our experts LIVE during one of the 4 presentations to get a deeper understanding of key issues impacting our value-driven healthcare environment. Request a time to meet.     PANEL: ARE EXISTING REGULATORY EVIDENCE STANDARDS ADEQUATE FOR INFORMING DECISIONS ON MEDICAL […]

EVERSANA Sponsors CADTH 2020

Analyze, Deliver, Measure, and Communicate Value Across the Product Lifecycle. EVERSANA is a Silver Sponsor of the Canadian Agency for Drugs and Technologies in Health (CADTH) in Toronto, Ontario, and  EVERSANA experts join industry colleagues to share their insight to more than 1000 attendees involved in the areas of policy-making, program decision-making, health care delivery, […]

EVERSANA Sponsors Rainmaker20

Learn how to Know and Grow Your True Top Line at Rainmaker20. Join the largest gathering of Model N users, partners, and thought leaders at the industry’s premier Revenue Management conference. You’ll gain valuable insights into how to maximize revenue at speed and scale across billions of revenue execution moments in your business, every day. […]

EVERSANA Sponsors Pharma Pricing & Market Access Congress 2020

UPDATE: PPMA 2020 has been postponed due to the COVID-19 Coronavirus travel bans that have been put in place. The event will take place on September 24-25, 2020.   EVERSANA is proud to be a Platinum Sponsor at this year’s World Pharma Pricing, Market Access & Evidence Congress (PPMA), taking place on September 24 and […]

End-to-End Commercialization Solutions

Innovative therapies allow for global innovative commercialization strategies. That’s why we’ve built a comprehensive integrated commercial services company, powered by more than 2,000 employees, to partner with Global pharmaceutical, biotech and emerging innovators to bring their products to market, with focus on the US market, reducing cost and risk while simultaneously improving outcomes. From European […]

ClinBiz Summit 2020

Connect with top-notch industry speakers  delivering impactful presentations with practical solutions and best practices to take you to the next level in leading and managing the business aspects of clinical trials. Meet the EVERSANA team to learn how we can help drive awareness programs, education and support services to promote adherence and better health outcomes. […]

SCOPE Summit 2020

More than 2000 executives interested in driving innovation in clinical trials and digital health will be gathered at the 11th annual SCOPE Summit for Clinical Ops Executives, held this year from February 18-21 in Orlando, FL. The four-day conference will cover in-depth discussions across 20 different conferences, feature 3 plenary keynote sessions and interactive breakout […]

Top 10 Questions for Digital Technology Companies Delivering Therapies.

Take the Digital Therapies Commercialization Quiz. Can your organization answer the top 10 questions required to avoid pitfalls and navigate the uniquely complicated and regulated healthcare market? Will someone (payer or patient) pay for my product? How are payers thinking about my disease? Who pays for this disease today? What’s the right business model and […]